C
KYMR icon

Covestor’s Kymera Therapeutics KYMR Stock Holding History

Covestor’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15K Buy
130
+16
+14% +$1.38K 0.01% 1303
2026
Q1 		$10K Buy
114
+110
+2,750% +$8.71K 0.01% 1405
2025
Q4 		$0 Hold
4
– – ﹤0.01% 2512
2025
Q3 		$0 Hold
4
– – ﹤0.01% 2530
2025
Q2 		$0 Sell
4
-29
-88% -$999 ﹤0.01% 2485
2025
Q1 		$1K Buy
33
+30
+1,000% +$1.09K ﹤0.01% 2019
2024
Q4 		$0 Hold
3
– – ﹤0.01% 2496
2024
Q3 		$0 Sell
3
-1
-25% -$44 ﹤0.01% 2481
2024
Q2 		$0 Hold
4
– – ﹤0.01% 2499
2024
Q1 		$0 Hold
4
– – ﹤0.01% 2499
2023
Q4 		$0 Sell
4
-1
-20% -$18 ﹤0.01% 2435
2023
Q3 		$0 Sell
5
-1
-17% -$20 ﹤0.01% 2417
2023
Q2 		$0 Hold
6
– – ﹤0.01% 2407
2023
Q1 		$0 Hold
6
– – ﹤0.01% 2317
2022
Q4 		$0 Hold
6
– – ﹤0.01% 2341
2022
Q3 		$0 Sell
6
-1
-14% -$26 ﹤0.01% 2309
2022
Q2 		$0 Hold
7
– – ﹤0.01% 2146
2022
Q1 		$0 Sell
7
-2
-22% -$84 ﹤0.01% 2281
2021
Q4 		$1K Buy
+9
New +$524 ﹤0.01% 1812

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Covestor's KYMR Position: Q2 2026 in Review

Covestor increased its Kymera Therapeutics (KYMR) stake by 14% in Q2 2026, buying an estimated $1.38K and bringing the position to 130 shares worth $15K. The position accounts for 0.01% of the portfolio, ranked #1303.

Covestor first reported a position in KYMR in Q4 2021 and has held it in 19 quarters since. 276 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Covestor held 130 shares of Kymera Therapeutics worth $15K as of Q2 2026.
  • Covestor bought 16 Kymera Therapeutics shares in Q2 2026, an estimated $1.38K.
  • Kymera Therapeutics made up 0.01% of Covestor's portfolio in Q2 2026, its #1303 holding.
  • Covestor first reported a position in Kymera Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • 276 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.